News

Find a News Story

Displaying 1021 - 1040 of 2230

Julia Matthiesen ’24

Young Artist Charts Course as Inaugural Malú Alvarez Visual Art Scholar

Julia Matthiesen ’24 is the inaugural recipient of the Malú Alvarez Visual Art Scholarship, created by artist and alumna Malú Alvarez ’02. In addition to art, Matthiesen is interested in computer science and is excited about the ways her interests will mesh at Ä¢¹½TV.

Economics Panel Participants on Zoom

Economy Getting a Vaccine, but Only for Some

Economic experts frequently disagree, but a Ä¢¹½TV-led national panel of four of them reached a consensus about the year ahead: The recovery will be swift…and uneven.

Tally Saves the Internet Exhibit text on wall in purple room, with screen projecting creature on pile of rubble

Tally Saves the Internet – and Your Privacy

Web trackers collect your data and auction it off to vendors who push you toward impulse buys. To fight back, Ä¢¹½TV professors Joelle Dietrick and Owen Mundy created Tally Saves the Internet, a multi-player game that blocks data trackers and educates players about data privacy.

Black Lives Matter Mural

Students Create Mural With Powerful Message

In a year that brought a pandemic, nationwide protests and a brighter spotlight on racial inequities and injustice, Ä¢¹½TV students came together to create a mural with a simple, powerful slogan of the ongoing social justice movement: BLACK LIVES MATTER.

James Shakow '22, Director of the Practice Fields Scene in Ubi Orta Pestilentia: A Ä¢¹½TV Zombie Apocalypse

Anatomy of a Pandemic Theatre Production

Theatre Prof Steve Kaliski ’07 and student directors embraced the challenge of creating in the time of COVID with a socially-distanced production titled “Ubi Orta Pestilentia: A Ä¢¹½TV Zombie Apocalypse.â€�

Sallie Permar in lab coat

NPR: COVID-19 Vaccine for Children May Still Be Many Months Away

In an interview with NPR’s All Things Considered, pediatrician and researcher Sallie Permar ’97 explained why the COVID-19 vaccines coming to market soon will not be available to children, who have been largely excluded from clinical trials.